Adverum Biotechnologies, Inc. (ADVM)
NASDAQ: ADVM · Real-Time Price · USD
2.870
-0.090 (-3.04%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Adverum Biotechnologies Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 60.65 | 75 | 68.43 | 34.2 | 62.42 | Upgrade
|
| Short-Term Investments | 65.04 | 21.53 | 117.16 | 270.99 | 367.31 | Upgrade
|
| Cash & Short-Term Investments | 125.69 | 96.53 | 185.59 | 305.19 | 429.73 | Upgrade
|
| Cash Growth | 30.21% | -47.99% | -39.19% | -28.98% | 158.82% | Upgrade
|
| Receivables | - | - | - | 5.71 | - | Upgrade
|
| Prepaid Expenses | 5.61 | 6.25 | 5.01 | 6.25 | 4.71 | Upgrade
|
| Total Current Assets | 131.3 | 102.77 | 190.6 | 317.15 | 434.44 | Upgrade
|
| Property, Plant & Equipment | 45.22 | 49.79 | 113.86 | 119.06 | 47.1 | Upgrade
|
| Other Long-Term Assets | 3.32 | 3.21 | 3.92 | 3.52 | 1.03 | Upgrade
|
| Total Assets | 179.84 | 155.77 | 308.37 | 439.73 | 482.57 | Upgrade
|
| Accounts Payable | 1.61 | 1.92 | 2.24 | 1.39 | 2.81 | Upgrade
|
| Accrued Expenses | 14.5 | 11.76 | 16.1 | 14.71 | 12.26 | Upgrade
|
| Current Portion of Leases | 5.67 | 5.48 | 13.24 | 1.89 | 4.47 | Upgrade
|
| Current Income Taxes Payable | 0.12 | 0.1 | 0.25 | 1.32 | 0.04 | Upgrade
|
| Other Current Liabilities | 1 | 0.73 | 0.42 | 2.02 | 1.29 | Upgrade
|
| Total Current Liabilities | 22.9 | 19.98 | 32.25 | 21.32 | 20.87 | Upgrade
|
| Long-Term Leases | 86.04 | 68.57 | 93.56 | 101.11 | 26.24 | Upgrade
|
| Other Long-Term Liabilities | 0.19 | - | 1.05 | 1.11 | 1.11 | Upgrade
|
| Total Liabilities | 109.13 | 88.55 | 126.85 | 123.54 | 48.22 | Upgrade
|
| Common Stock | 0 | 0 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 1,138 | 1,004 | 985.65 | 964.97 | 937.13 | Upgrade
|
| Retained Earnings | -1,067 | -936.02 | -802.61 | -648.08 | -502.54 | Upgrade
|
| Comprehensive Income & Other | -0.41 | -0.47 | -1.53 | -0.71 | -0.26 | Upgrade
|
| Shareholders' Equity | 70.71 | 67.22 | 181.52 | 316.19 | 434.35 | Upgrade
|
| Total Liabilities & Equity | 179.84 | 155.77 | 308.37 | 439.73 | 482.57 | Upgrade
|
| Total Debt | 91.71 | 74.04 | 106.8 | 102.99 | 30.71 | Upgrade
|
| Net Cash (Debt) | 33.99 | 22.49 | 78.79 | 202.19 | 399.02 | Upgrade
|
| Net Cash Growth | 51.15% | -71.46% | -61.03% | -49.33% | 198.47% | Upgrade
|
| Net Cash Per Share | 1.72 | 2.23 | 7.94 | 20.62 | 46.86 | Upgrade
|
| Filing Date Shares Outstanding | 20.89 | 20.75 | 10.06 | 9.88 | 9.78 | Upgrade
|
| Total Common Shares Outstanding | 20.85 | 10.14 | 10.01 | 9.84 | 9.75 | Upgrade
|
| Working Capital | 108.4 | 82.79 | 158.35 | 295.83 | 413.57 | Upgrade
|
| Book Value Per Share | 3.39 | 6.63 | 18.13 | 32.14 | 44.53 | Upgrade
|
| Tangible Book Value | 70.71 | 67.22 | 181.52 | 316.19 | 434.35 | Upgrade
|
| Tangible Book Value Per Share | 3.39 | 6.63 | 18.13 | 32.14 | 44.53 | Upgrade
|
| Machinery | 15.86 | 15.51 | 16.58 | 15.14 | 11.21 | Upgrade
|
| Construction In Progress | 0.01 | 0.18 | 1.01 | 4.4 | 1.95 | Upgrade
|
| Leasehold Improvements | 13.78 | 13.59 | 34.34 | 26.7 | 24.63 | Upgrade
|
Updated Apr 15, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.